Estrogen regulates vesicle trafficking gene expression in EFF-3, EFM-19 and MCF-7 breast cancer cells

International Journal of Clinical and Experimental Pathology

Volumn 2, Issue 5, 2009, Pages 463-475

  Wright, Paul K ^a,b   May, Felicity E B ^a   Darby, Steve ^a   Saif, Rehan ^a,b   Lennard, Tom W J ^b   Westley, Bruce R ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Breast cancer; Estrogen; Exocytosis; RAB GTPase; Synaptotagmin like protein; Vesicle

Indexed keywords

EID: 66949112236     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Nilsson S, Makela S, Treuter E, Tujaque M, Thomsen J, Andersson G, Enmark E, Pettersson K, Warner M and Gustafsson JA. Mechanisms of estrogen action. Physiol Rev 2001;81:1535-1565.
2. Ackermann GE and Carr BR. Estrogens. Rev Endocr Metab Disord 2002;3:225-230.
3. Osborne CK and Schiff R. Estrogen-receptor biology: continuing progress and therapeutic implications. J Clin Oncol 2005;23:1616-1622.
4. Doisneau-Sixou SF, Sergio CM, Carroll JS, Hui R, Musgrove EA and Sutherland RL. Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells. Endocr Relat Cancer 2003;10:179-186.
5. Cunliffe HE, Ringner M, Bilke S, Walker RL, Cheung JM, Chen Y and Meltzer PS. The gene expression response of breast cancer to growth regulators: patterns and correlation with tumor expression profiles. Cancer Res 2003;63: 7158-7166.
6. Johnson, MD, Westley and May FEB. Oestrogenic activity of tamoxifen and its metabolites on gene regulation and cell proliferation in MCF-7 breast cancer cells. Br J Cancer 1989;59:727-738.
7. Platet N, Cathiard AM, Gleizes M and Garcia M. Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. Crit Rev Oncol Hematol 2004; 51:55-67.
8. Frasor J, Danes JM, Komm B, Chang KC, Lyttle CR and Katzenellenbogen BS. Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: Insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 2003;144: 4562-4574.
9. Soulez M and Parker MG. Identification of novel oestrogen receptor target genes in human ZR75-1 breast cancer cells by expression profiling. J Mol Endocrinol 2001;27: 259-274.
10. Rae JM, Johnson MD, Scheys JO, Cordero KE, Larios JM and Lippman ME. GREB1 is a critical regulator of hormone dependent breast cancer growth. Breast Cancer Res Treat 2005;92:141-149.
11. Kininis M, Chen BS, Diehl AG, Isaacs GD, Zhang T, Siepel AC, Clark AG and Kraus WL. Genomic analysis of transcription factor binding, histone acetylation and gene expression reveal mechanistically distinct classes of estrogen-regulated genes. Mol Cell Biol 2007;27:5090-5104.
12. Yu J, Yu J, Cordero KE, Johnson MD, Ghosh D, Rae JM, Chinnaiyan AM and Lippman ME. A transcriptional fingerprint of estrogen in human breast cancer predicts patient survival. Neoplasia 2008;10:79-88.
13. Westley BR and May FEB. Identification of steroid hormone-regulated genes in breast cancer. Methods Mol Med 2006;120:363-388.
14. May FEB and Westley BR. Cloning of estrogen-regulated messenger sequences from human breast cancer cells. Cancer Res 1986;46: 6034-6040.
15. Henry JA, Nicholson S, Hennessy C, Lennard TWJ, May FEB and Westley BR. Expression of the oestrogen regulated pNR-2 mRNA in human breast cancer: relation to oestrogen receptor mRNA levels and response to tamoxifen therapy. Br J Cancer 1990;61:32-38.
16. Prest SJ, May FE and Westley BR. The estrogen-regulated protein, TFF1, stimulates migration of human breast cancer cells. FASEB J 2002; 16:592-594.
17. Simon WE, Albrecht M, Trams G, Dietel M and Holzel F. In vitro growth promotion of human mammary carcinoma cells by steroid hormones, tamoxifen, and prolactin. J Natl Cancer Inst 1984;73:313-321.
18. Healicon RM, Westley BR and May FEB. Isolation and characterization of an oestrogen-responsive breast cancer cell line, EFF-3. Int J Cancer 1993;53:388-394.
19. Burgoyne RD and Morgan A. Secretory granule exocytosis. Physiol Rev 2003;83:581-632.
20. Jordens I, Marsman M, Kuijl C and Neefjes J. Rab proteins, connecting transport and vesicle fusion. Traffic 2005;6:1070-1077.
21. Chan AM and Weber T. A putative link between exocytosis and tumor development. Cancer Cell 2002;2:427-428.
22. Palmer RE, Bong Lee S, Wong JC, Reynolds PA, Zhang H, Truong V, Oliner JD, Gerald WL and Haber DA. Induction of BAIAP3 by EWS-WT1 chimeric fusion implicates regulated exocytosis in tumorigenesis. Cancer Cell 2002;2:497-505.
23. Wright PK. Targeting vesicle trafficking: An important approach to cancer chemotherapy. Recent Patents Anti-Cancer Drug Discov 2008; 3:137-147
24. Bertucci F, Viens P, Tagett R, Nguyen C, Houlgatte R and Birnbaum D. DNA arrays in clinical oncology: promises and challenges. Lab Invest 2003;83:305-316.
25. Westley BR and May FEB. Oestrogen regulates oestrogen receptor mRNA levels in an oestrogen-responsive human breast cancer cell line. Biochem Biophys Res Commun 1988; 155:1113-1118.
26. Majo G, Lorenzo MJ, Blasi J and Aguado F. Exocytotic protein components in rat pituitary gland after long-term estrogen administration. J Endocrinol 1999;161:323-331.
27. Chen D, Ganpathy P, Zhu L, Xu X, Li Q, Bagchi IC and Bagchi MK. Potential regulation of membrane trafficking by estrogen receptor a via induction of rab11 in uterine glands during implantation. Mol Endocrinol 1999;13:993-1004.
28. Vic P, Vignon F, Derocq D and Rochefort H. Effect of estradiol on the ultrastructure of the MCF-7 human breast cancer cells in culture. Cancer Res 1982;42:667-673.
29. Kuroda TS, Fukuda M, Ariga H and Mikoshiba K. Synaptotagmin-like protein 5: a novel Rab27A effector with C-terminal tandem C2 domains. Biochem Biophys Res Commun 2002;293:899-906.
30. Fukuda M. Versatile role of Rab27 in membrane trafficking: focus on the Rab27 effector families. J Biochem (Tokyo) 2005;137: 9-16.
31. Johnson JL, Ellis BA, Noack D, Seabra MC and Catz SD. The Rab27a binding protein, JFC1, regulates the androgen-dependent secretion of prostate-specific antigen and prostate-specific acid phosphatase. Biochem J 2005;391:699-710.
32. Ramalho JS, Tolmachova T, Hume AN, McGuigan A, Gregory-Evans CY, Huxley C and Seabra MC. Chromosomal mapping, gene structure and characterization of the human and murine RAB27B gene. BMC Genet 2001; 2:2e.
33. Montrel V, Huang T, Mose E, Pesonjamasp K and Tarin D. Expression profiling of primary tumours and matched lymphatic and lung metastases in a xenogeneic breast cancer model. Am J Path 2005;166:1565-1579.
34. Worby CA and Dixon JE. Sorting out the cellular functions of sorting nexins. Nat Rev Mol Cell Biol 2002;3:919-931.
35. Nguyen LN, Holdren MS, Nguyen AP, Furuya MH, Bianchini M, Levy E, Mordoh J, Liu A, Guncay GD, Campbell JS and Parks WT. Sorting Nexin 1 Down-Regulation Promotes Colon Tumourigenesis. Clin Cancer Res 2006;12: 6952-6959.
36. Fuchs U, Rehkamp G, Hass OA, Slany R, Konig M, Bojesen S, Bohle RM, Damm-Welk C, Ludwig WD, Harbott J and Borkhardt A. The human formin-binding protein 17 (FBP17) interacts with sorting nexin, SNX2, and is an MLL-fusion partner in acute myelogenous leukaemia. Proc Natl Acad Sci USA 2001;98:8756-8761.
37. Watahiki A, Waki K, Hayatsu N, Shiraki T, Kondo S, Nakamura M, Sasaki D, Arakawa T, Kawai J, Harbers M, Hayashizaki Y and Carninci P. Libraries enriched for alternatively spliced exons reveal splicing patterns in melanocytes and melanomas. Nature Methods 2004;1:233-239.
38. Osman I, Bajorin DF, Sun TT, Zhong H, Douglas D, Scattergood J, Zheng R, Han M, Marshall KW and Liew CC. Novel blood biomarkers of human urinary bladder cancer. Clin Cancer Res 2006; 12:3374-3380.
39. Bennett EP, Hassan H, Mandel U, Mirgorodskaya E, roepstorff P, Burchell J, Taylor-Papadimitriou J, Hollingsworth MA, Merkx G, van Kessel AG, Eiberg H, Steffensen R and Clausen H. Cloning of a human UDP-N-acetyl-α-D-galactosamine :polypeptide N-acetylgalactosaminyltransferase that complements other GalNAc-transferases in complete O-glycosylation of the MUC1 tandem repeat. J Biol Chem 1998;27:30472-30481.
40. Hebert SC, Mount DB and Gamba G. Molecular physiology of cation-coupled Cl- cotransport: the SLC12 family. Pflugers Arch - Eur J Physiol 2004;447:580-593.
41. A receptors in juvenile bovine adrenal chromaffin cells. J Neurophysiol 2003;90: 3828-3837.
42. Schillingford JM, Miyoshi K, Flagella M, Shull GE and Hennighasuen L. Mouse mammary epithelial cells express the Na-K-Cl cotransporter, NKCC1: Characterization, localization and involvement in ductal development and morphogenesis. Mol Endocrinol 2002;16:1309-1321.
43. Montalbano J, Jin W, Sheikh MS and Huang Y. RBEL1 Is a novel gene that encodes a nucleocytoplasmic Ras superfamily GTP-binding protein and Is overexpressed in breast cancer. J Biol Chem 2007;282:37640-37649.
44. Nishimura Y, Yoshiokab K, Bernardc O, Himenoa M and Itohb K. LIM kinase 1: evidence for a role in the regulation of intracellular vesicle trafficking of lysosomes and endosomes in human breast cancer cells. Eur J Cell Biol 2004;83:369-380.
45. Kominsky SL, Argani P, Korz D, Evron E, Raman V, Garrett E, Rein A, Sauter G, Kallioniemi OP and Sukumar S. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene 2003;22:2021-2033.
46. Bravo-Cordero JJ, Marrero-Diaz R, Megi D, Genis L, García-Grande A, Garcia MA, Arroyo AG and Montoya MC. MT1-MMP proinvasive activity is regulated by a novel Rab8-dependent exocytic pathway. EMBO J 2007;26:1499-1510.
47. Jayachandran G, Sazaki J, Nishizaki M, Xu K, Girard L, Minna JD, Roth JA and Ji L. Fragile histidine triad-mediated tumor suppression of lung cancer by targeting multiple components of the Ras/Rho GTPase molecular switch. Cancer Res 2007;67:10379-10388.
48. Cheng KW, Lahad JP, Kuo WL, Lapuk A, Yamada K, Auersperg N, Liu J, Smith-McCune K, Lu KH, Fishman D, Gray JW and Mills GB. The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers. Nat Med 2004;10:1251-1256.
49. Cheng KW, Lahad JP, Gray JW and Mills GB. Emerging role of RAB GTPases in cancer and human disease. Cancer Res 2005;65:2516-2519.
50. Hou Q. Wu YH, Grabsch H, Zhu Y, Leong SH, Ganesan K, Cross D, Tan LK, Tao J, Gopalakrishnan V, Tanq BL, Kon OL and Tan P. Integrative genomics identifies RAB23 as an invasion mediator gene in diffuse-type gastric cancer. Cancer Res 2008;68:4623-4630.
51. Steeg PS. New insights into the tumor metastatic process revealed by gene expression profiling. Am J Path 2005;166: 1291-1294.
52. Hugel B, Martinez MC and Freyssinet J. Membrane microparticles: Two sides of the coin. Physiology 2005;20:22-27.
53. Fevrier B and Raposo G. Exosomes: endosomal-derived vesicles shipping extracellular messages. Curr Opin Cell Biol 2004;16:415-421.
54. Taylor DD and Black PH. Shedding of plasma membrane fragments. Neoplastic and developmental importance. Dev Biol 1985;3: 33-57.
55. Ratajczak J, Miekus K, Kucia M, Zhang J, Reca R, Dvorak P and Ratajczak MZ. Embryonic stem cell-derived microvesicles reprogram hematopoetic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukaemia 2006;20;847-856.
56. Baj-Krzyworzeka M, Szatanek R, Weglarczyk K, Baran J, Urbanowicz B, Branski P, Ratajczak MZ and Zembala M. Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes. Cancer Immunol Immunother 2006;55:808-818.
57. Andre F, Schartz NE, Movassagh M, Flament C, Pautier P, Morice P, Pomel C, Lhomme C, Escudier B, Le Chevalier T, Tursz T, Amigorena S, Raposo G, Anqevin E and Zitvogel L. Malignant effusions and immunogenic tumour-derived exosomes. Lancet 2002;360:295-305.
58. Graves LE, Ariztia EV, Navari JR, Matzel HJ, Stack MS and Fishman DA. Proinvasive properties of ovarian cancer ascites-derived membrane vesicles. Cancer Res 2004;64: 7045-7049.
59. Kim CW, Lee HM, Lee TH, Kang C, Kleinman HK and Gho YS. Extracellular membrane vesicles from tumor cells promote angiogenesis via sphingomyelin. Cancer Res 2002;62:6312-6317.
60. Kim JW, Wieckowski E, Taylor DD, Reichert TE, Watkins S and Whiteside TL. Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes. Clin Cancer Res 2005;11:1010-1020.
61. Schnaeker EM, Ossig R, Ludwig T, Dreier R, Oberleithner H, Wilhelmi M and Schneider SW. Microtubule-dependent matrix metalloproteinase-2/ matrix metalloproteinase-9 exocytosis: prerequisite in human melanoma cell invasion. Cancer Res 2004;64:8924-8931.
62. Valenti R, Huber V, Iero M, Filipazzi P, Parmiani G and Rivoltini L. Tumor-released microvesicles as vehicles of immunosuppression. Cancer Res 2007;67:2912-2915.
63. Yu JL, May L, Lhotak V, Shahrzad S, Shirasawa S, Weitz JI, Coomber BL, Mackman N and Rak JW. Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. Blood 2005;105:1734-1741.
64. Yu X, Harris SL and Levine AL. (2006). The regulation of exosome secretion: a novel function of the p53 protein. Cancer Res 2006; 66:4795-4801.